Test
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
N- alpha -Fmoc-L-phenylalanine, CAS#35661-40-6; Reagent for ABI peptide synthesizer
Synonyms: Succinyl-L-Alanyl-L-Leucyl-L-Prolyl-L-Phenylalanine p-Nitroanilide, Application: Substrate for PPlase (Peptidyl-prolyl cis-trans Isomerase), Storage Temperature: -20°C
This item has a minimum order quantity of 3 per supplier requirements
Synonyms: Acetyl-L-Phenylalanine Ethyl Ester, Purity: , Grade AA, Application: Fluorescence-Quenching Substrate for ACE2 (TBC5180), Storage Temperature: -20C
Fmoc-b,b-diphenyl-Ala-OH, 201484-50-6, C30H25NO4, Mr 463.53, 5g. Fmoc-b-phenyl-Phe-OH, Fmoc-Dip-OH, Fmoc-3,3-diphenyl-L-alanine. Derivative for the introduction of Dip, a sterically hindered highly lipophilic phenylalanine substitute.
This item has a minimum order quantity of 4 per supplier requirements
Synonyms: L-Phenylalanine 4-Methyl-Coumaryl-7-Amide, Phe-AMC, Purity: , Grade AA, Application: Substrate for Aminopeptidase, Salt Form:, Tosylate Form, Storage Temperature: -20C
H-b-(2-Thienyl)-Ala-OH, 22951-96-8, C7H9NO2S, Mr 171.22, 5g. L-b-(2-Thienyl)-alanine (H-Thi-OH) is structurally similar to L-phenylalanine. H-Thi-OH inhibits the growth of Escherichia coli, presumably by competitive inhibition of enzymes for which Phe is the substrate.
p-I-L-Phe4 human beta amyloid (1-40) - 1mg , Asp-Ala-Glu-p-I-L-Phenylalanine-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH Category/Application: Alzheimer's This item is non returnable
This item has a minimum order quantity of 2 per supplier requirements
Synonyms: Succinyl-L-Alanyl-L-Alanyl-L-Prolyl-L-Phenylalanine 4-Methyl-Coumaryl-7-Amide, Suc-Ala-Ala-Pro-Phe-AMC, Suc-AAPF-AMC, Suc-AAPF-MCA, Purity: , Grade A, Application: Substrate for Chymotrypsin, Storage Temperature: -20C, References: S. Sawada, H. Yokasawa, M. Hoshi and S. Ishii, Experientia, 39, 377 (1983).
Empirical Formula (Hill Notation): C69H108N22O16S · xC2HF3O2, Molecular Weight: 1533.80 (free base basis), ≥96% (HPLC), Synonym: 5-Oxo-L-prolyl-L-arginyl-L-prolyl-L-arginyl-L-leucyl-L-seryl-L-histidyl-L-lysylglycyl-L-prolyl-L-methionyl-L-prolyl-L-phenylalanine TFA, Pyroglutamated apelin-13, Pyroglutaminated apelin-13, Pyroglutamyl apelin-13, [Glp1]-Apelin-13, [Pyr-1]-apelin-13, [Pyr]-apelin-13, [pGlu1]-apelin-13, pERPRLSHKGPMPF TFA, pGlu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe, TFA.
This is a negative control peptide containing the reversed sequence of the first two amino acids of the receptor-activating (tethered ligand) peptide SFLLRN-NH2. It shows no detectable affinity for the binding sites. Whereas SFLLRN-NH2 effectively displaces [3H]haTRAP, thrombin receptor-activating peptide, the same peptide with serine and phenylalanine reversed, FSLLRN-NH2, does not.SEQUENCE: H-Phe-Ser-Leu-Leu-Arg-Asn-NH2 (trifluoroacetate salt)ONE-LETTER SEQUENCE: FSLLRN-NH2MOLECULAR FORMULA: C34H57N11O8MOLECULAR WEIGHT: 747.89STORAGE CONDITIONS: -20 5 CCAS REGISTRY NUMBER: [374898-11-0]SYNONYMS: (Phe,Ser)-Thrombin Receptor Activator Peptide 6, (Phe,Ser)-Thrombin Receptor 1 (1-6) (human), (Phe,Ser)-PAR-1 (1-6) (human), (Phe,Ser)-Proteinase Activated Receptor 1 (1-6) (human), FSLLRN, (Phe,Ser)-Coagulation Factor II Receptor (1-6) (human)RESEARCH AREA: Hematology, CardiovascularREFERENCES:Ahn, HS. et al. Mol. Pharmacol. 51, 350 (1997)SKU(s): THRO-006A,
Amyloid Beta Protein (4-42) Ammonium, H-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH, 157884-72-5, C191H294N52O53S, Mr 4198.82, 0.5mg. Ab (4-42). Ab 4-42 could be one of the earliest and most prominent Ab species deposited in AD brain. Sequencing of amyloid plaque cores showed that 64% of the isolated Ab had a phenylalanine at its N-terminus, and indeed, IP/MS experiments identified Ab 4-42 as a major Ab species in AD patients. Additionally, Ab 4-42 was found to be a component of cotton wool plaques in familial AD patients with the V261I PS1 mutation. Ab 4-42 was discovered as well in amyloid deposits from vascular dementia and familial Danish dementia patients. These observations indicate that Ab 4-42 may contribute to the development of multiple CNS diseases.